Programmatic Audio and Digital Out-of-Home for Healthcare

Audio and DOOH tend to get added to healthcare plans late, as a reach extension after video and display are set. That is a reasonable place for them, but the rules and measurement are different enough that copying the display setup does not work. A 15-second audio spot that works for a retailer cannot carry a branded drug's risk information. A pharmacy screen that shows a slide for eight seconds cannot carry a scrolling ISI. The guide to programmatic advertising in healthcare covers where these channels fit next to the others.

Programmatic audio for healthcare: what is available

• Streaming music and radio apps, sold through audio SSPs and most major DSPs, with targeting by geography, daypart, genre, and sometimes audience data.
• Podcasts, sold programmatically as dynamically inserted ads, or directly as host-read or sponsorship deals. Health and wellness podcasts are a natural contextual fit.
• Digital radio simulcasts, which carry broadcast radio streams with digital ad insertion.

Audio reaches people in moments when they are not looking at screens: driving, exercising, cooking. For conditions with an active patient community, health podcasts offer context that resembles endemic media. For HCPs, a few medical podcasts and professional audio programs exist, but scale is small.

Audio fair balance rules for branded pharma ads

A summary for planning, not regulatory advice. FDA's rules at 21 CFR 202.1 treat radio as a broadcast medium. A branded product claim ad on radio needs a major statement of the drug's most important risks, presented in the audio, plus an adequate provision for the full prescribing information (commonly a website, a toll-free number, a reference to a print ad, and a reminder to ask a healthcare provider). FDA's final rule on the major statement in TV and radio ads, which took effect in 2024, set standards for presenting it in a clear, conspicuous, and neutral way, including language consumers can understand and no distracting audio. Check the current version with your regulatory team.

Most pharma companies treat streaming audio and podcast ads the same as radio, since the listener experience is the same. In practice this means:

• Branded product claim spots usually run 60 seconds, sometimes longer, to fit the major statement.
• Background music and sound effects need to drop out or stay neutral during the risk section.
• Host-read podcast ads must follow the approved script. Ad libs, personal stories about using the drug, and casual claims are where most problems start.
• Reminder ads (name only, no claim) are shorter but not allowed for drugs with a boxed warning.
• Unbranded help-seeking spots avoid most of these requirements and work well in 15 or 30 second formats.

The equivalent rules for visual formats are in fair balance in digital pharma ads.

Healthcare DOOH: pharmacies, medical offices, and beyond

Point-of-care networks in medical offices often sit between DOOH and endemic media. Many are bought direct, with programmatic access growing. Silent screens with short dwell time make branded product claim ads hard, because the risk information has to appear with comparable prominence to the benefit claim. Longer-dwell venues with full-screen formats handle it better. DOOH also pairs naturally with environmental triggers, such as running allergy messages on screens in high-pollen markets, which is covered in dynamic targeting and dynamic creative in pharma.

Measuring programmatic audio and DOOH

Neither channel produces a click you can rely on, so measurement needs a comparison. Options, in rough order of rigor:

1. Geographic holdout. Run audio or DOOH in some markets and not in matched others, then compare outcomes (prescriptions, site visits, appointment requests). This is the cleanest design for both channels.
2. Venue-level comparison for DOOH. Compare outcomes near exposed pharmacies or offices against matched unexposed venues. Works best when outcome data is available at a local level.
3. Outcomes studies on exposure files. Some audio platforms can produce household or device-level exposure files for matching to outcomes data. Check the identity method and privacy basis.
4. Brand lift surveys. Useful for awareness and message recall, weak as proof of behavior.
5. Device-level DOOH exposure from location data. Possible, but tracking devices near pharmacies and medical offices is exactly the kind of health-related location data that state laws, including Washington's My Health My Data Act, restrict. Get a privacy review before using it.

For DOOH impressions, ask how the network counts audience: screen plays, estimated viewers, or verified impressions under MRC-aligned methods. Those numbers can differ a lot for the same screen. The measurement side of point-of-care networks is covered in point-of-care campaign measurement.

What usually goes wrong

• Buying 30-second audio spots for a branded product claim ad and then discovering the risk section does not fit.
• Letting podcast hosts improvise around the approved script.
• Running branded display creative on silent pharmacy screens without adapting the risk presentation.
• Reporting DOOH "impressions" from screen plays as if they were people reached.
• Adding both channels to every market, which removes any chance of a geographic comparison.

Practical takeaway

If you are adding audio or DOOH this year, hold out a set of matched markets from the start and write the measurement plan before buying. For audio, decide early whether the spot is branded (plan for 60 seconds with a spoken major statement) or unbranded (15 to 30 seconds), and get the script through MLR before booking podcast inventory.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.